PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 24 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Krukovine exhibited potent anti-plasmodial activity in vitro against both chloroquine-resistant (K1) and chloroquine-sensitive (T9-96) strains [PMID:10418326]. Crude alkaloid extracts showed activity in vivo against Plasmodium berghei [PMID:16713157].
In a rat model, Abuta grandifolia was evaluated for its effect on renal function following ischemia and reperfusion injury [PMID: 37443721].
Krukovine inhibited the growth and proliferation of KRAS-mutated non-small cell lung cancer (NSCLC) cell lines (H460 and A549) [PMID: 30186180].
Krukovine showed antiproliferative effects in patient-derived pancreatic cancer organoids (PDPCOs) and suppressed tumor progression in AsPC-1 cells [PMID: 37174108].
Ethanol extracts of stem bark showed significant antimicrobial effects [PMID: 17178202], and decoctions partially inhibited the growth of Pseudomonas aeruginosa and Mycobacterium gordonae [PMID: 8850132].
Evidence summary
PubMed sources
- 1.PMID: 37443721 (2023) — Amazonia Phytotherapy Reduces Ischemia and Reperfusion Injury in the Kidneys. · Cells
- 2.PMID: 22230193 (2012) — New cholinesterase inhibiting bisbenzylisoquinoline alkaloids from Abuta grandifolia. · Fitoterapia
- 3.PMID: 37174108 (2023) — Antiproliferative Activity of Krukovine by Regulating Transmembrane Protein 139 (TMEM139) in Oxaliplatin-Resistant Pancreatic Cancer Cells. · Cancers
- 4.PMID: 10418326 (1999) — Evaluation of the anti-plasmodial activity of bisbenzylisoquinoline alkaloids from Abuta grandifolia. · Planta medica
- 5.PMID: 16713157 (2006) — Antimalarial activity of some Colombian medicinal plants.